# A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease

> **NCT02912936** · NA · COMPLETED · sponsor: **University of British Columbia** · enrollment: 43 (actual)

## Conditions studied

- Alzheimer's Disease
- Primary Progressive Non-fluent Aphasia
- Frontotemporal Dementia (FTD)

## Interventions

- **DIETARY_SUPPLEMENT:** Ketogenic medium chain triglyceride drink (MCT drink)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02912936
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2020-02-04
- **Final completion:** 2020-03-01
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02912936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02912936, "A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02912936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*